CORETOX® in Treatment of Post Stroke Upper Limb Spasticity

Recruiting

Phase 3 Results N/A

Trial Description

The purpose of this study is to evaluate the efficacy and safety of CORETOX® in the treatment of Post stroke upper limb spasticity

Conditions

Interventions

  • Botox® Drug
    Intervention Desc: upper limb will be injected and evaluated in the study. Maximun injection dose is 360U.
    ARM 1: Kind: Experimental
    Label: BOTOX®
  • CORETOX® Drug
    Intervention Desc: upper limb will be injected and evaluated in the study. Maximun injection dose is 360U.
    ARM 1: Kind: Experimental
    Label: CORETOX®

Outcomes

Type Measure Time Frame Safety Issue
Primary MAS(Modified Ashworth Scale)of wrist flexor 4 weeks
Secondary MAS(modified Ashworth Score)of elbow and finger flexor 4 weeks after injection
Secondary MAS(modified Ashworth Score)of wrist, elbow and finger flexor 8, 12 weeks after injection
Secondary Percentage of treatment responder at week 4, 8, 12 after injection 4, 8, 12 weeks after injection

Sponsors